PTX Share Price

Open 3.05 Change Price %
High 3.11 1 Day 0.03 0.97
Low 2.97 1 Week 0.36 13.09
Close 3.11 1 Month -0.58 -15.72
Volume 152170 1 Year 0.40 14.76
52 Week High 4.80
52 Week Low 0.39
PTX Important Levels
Resistance 2 3.24
Resistance 1 3.19
Pivot 3.06
Support 1 3.03
Support 2 2.98
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
RBY 0.03 -70.00%
NGD 3.93 5.65%
NGD 3.93 5.65%
NAK 1.52 7.04%
NAK 1.52 7.04%
PBTH 8.23 0.37%
PLX 0.30 -9.09%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
SIF 8.65 -18.40%
WGA 0.18 -18.18%
More..

Pernix Therapeutics Holdings, Inc. (AMEX: PTX)

PTX Technical Analysis 3
As on 7th Dec 2016 PTX Share Price closed @ 3.11 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.44 & Buy for SHORT-TERM with Stoploss of 2.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
PTX Target for December
1st Target up-side 3.84
2nd Target up-side 4.42
3rd Target up-side 5
1st Target down-side 2.2
2nd Target down-side 1.62
3rd Target down-side 1.04
PTX Other Details
Segment EQ
Market Capital 220918032.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.pernixtx.com
PTX Address
PTX
10863 Rockley Road
Houston, TX 77099
United States
Phone: 832-934-1825
Fax: 800-793-2145
Interactive Technical Analysis Chart Pernix Therapeutics Holdings, Inc. ( PTX AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pernix Therapeutics Holdings, Inc.
PTX Business Profile
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. The company’s product include CEDAX, a oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; REZIRA, ZUTRIPRO, and VITUZ, which are oral solutions for the relief of cough and nasal congestion; and OMECLAMOX-PAK to treat patients with H.pylori infection and duodenal ulcer disease. Its products also comprise SILENOR, a prescription medicine used to treat insomnia characterized by difficulty with sleep maintenance; KHEDEZLA, a prescription medicine for the treatment of major depressive disorder; and NATROBA, a prescription medicine used to treat head lice. In addition, the company offers various generic pharmaceutical products in the areas of nutritional supplements, analgesics, urinary tract, women’s health, pre-natal vitamins, and dental health, as well as allergy, respiratory, iron deficiency, nephrology, and pain management. It serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies in the United States. The company was founded in 1996 and is based in Houston, Texas.